Alnylam Pharmaceuticals, Inc.
Charles Elliott Sigal (Director) buys ALNY shares
AI-generated summary
Director Charles Elliott Sigal bought 1,600 shares of Common Stock at an average price of $152.25 for a total value of $243,600 on November 10, 2026. Following this transaction, he indirectly holds 3,600 shares by Trust.
Key facts
- Insider
- Charles Elliott Sigal · Director
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Nov 10, 2026 | P · purchaseFootnotes F1 | +1,600 | $152.25 | $243,600.00 | 3,600 | Indirect (by Trust) |
Footnotes
- F1 Shares held by Sigal Family Investments, LLC, of which the reporting person is Managing Member.
More ALNY filings
- 4
Filed Nov 12, 2026
- 4
Filed Nov 12, 2026
- SC 13G/A
Filed Nov 5, 2026
- 8-K
Filed Nov 5, 2026
- SC 13G
Filed Oct 30, 2026
- 10-Q
Filed Oct 29, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.